Topic Highlight
Copyright ©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 21, 2015; 21(39): 11053-11076
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.11053
Endocrine causes of nonalcoholic fatty liver disease
Laura Marino, François R Jornayvaz
Laura Marino, François R Jornayvaz, Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital, 1011 Lausanne, Switzerland
Author contributions: Both authors wrote the manuscript.
Conflict-of-interest statement: The authors declare no conflict of interests.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
Correspondence to: François R Jornayvaz, MD, Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital, Rue du Bugnon 46, 1011 Lausanne, Switzerland.
Telephone: +41-213140622 Fax: +41-213140630
Received: April 14, 2015
Peer-review started: April 16, 2015
First decision: May 18, 2015
Revised: June 11, 2015
Accepted: August 28, 2015
Article in press: August 28, 2015
Published online: October 21, 2015
Core Tip

Core tip: The review discusses the links between nonalcoholic fatty liver disease and endocrine diseases, from common ones such as type 2 diabetes and polycystic ovary syndrome to rare disorders such as growth hormone deficiency. The pathophysiological mechanisms underlying these associations are described.